| [1] |
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet, 2012, 380(9859):2095-128.
|
| [2] |
郑徽，崔富强，龚晓红，等. 我国育龄期妇女乙型肝炎病毒表面抗原及e抗原流行现状分析[J]. 中国疫苗和免疫，2010, 16(6):496-499.
|
| [3] |
Lai CL, Ratziu V, Yuen MF, et al. Viral hepatitis B[J]. Lancet, 2003, 362(9401):2089-2094.
|
| [4] |
乙型肝炎病毒感染女性生育管理专家委员会. 乙型肝炎病毒感染女性生育管理专家共识[J/CD]. 中华实验和临床感染病杂志：电子版，2014, 8(1):104-107.
|
| [5] |
何进球，袁松华，冼革坚，等. 乙型肝炎病毒阳性父-婴垂直传播的临床研究[J]. 实用妇产科杂志，2005, 21(5):301-303.
|
| [6] |
张俊新，杨永梅，李琼芬，等. 育龄期慢性乙肝病毒感染者治疗策略和垂直传播风险探讨[J]. 现代预防医学，2012, 39(7):1795-1797.
|
| [7] |
刘金涛. 乙型肝炎病毒父婴垂直传播及其相关标志物检测的研究进展[J]. 实用检验医师杂志，2014, 6(4):244-247.
|
| [8] |
慢性乙型肝炎特殊患者抗病毒治疗专家委员会慢性乙型肝炎特殊患者抗病毒治疗专家共识：2015年更新[J]. 临床肝胆病杂志，2015, 31(8):1185-1192.
|
| [9] |
Han GR, Cao MK, Zhao W, et al. A prospective and open—label study for the efficacy and safety of telbivudine in pregnancy for theprevention of perinatal transmission of hepatitis B virus infection[J]. J Hepatol, 2011, 55(6):1215-1221.
|
| [10] |
陈川英，涂相林，程全红，等. 慢性乙型肝炎患者妊娠早期替比夫定抗病毒的疗效及母婴阻断的临床观察[J]. 中华肝脏病杂志，2015, 1(23):9-12.
|
| [11] |
Pan CQ, Duan Z, Dai E, et al. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load[J]. N Engl J Med, 2016, 374(24):2324-2334.
|
| [12] |
Han GR, Jiang HX, Wang CM, et al, Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy[J]. J Viral Hepat, 2017, 24(6):514-521.
|
| [13] |
中华医学会肝病学分会，中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015更新版)[J]. 中华肝脏病杂志，2015, 23(12):888-905.
|
| [14] |
Lok AS, McMahon BJ, Brown RS Jr, et al. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis[J]. Hepatology, 2016, 63(1):319-333.
|
| [15] |
Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update[J]. Hepatol Int, 2016, 10(1):1-98.
|
| [16] |
Terrault NA, Bzowej NH, Chang KM, et al. AASLD guidelines for treatment of chronic hepatitis B[J]. Hepatology, 2016, 63(1):261-283.
|
| [17] |
Zhang L, Gui XE, Teter C, et al. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine[J]. Vaccine, 2014, 32(46):6091-6097.
|
| [18] |
Liang X, Bi S, Yang W, Wang L, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China[J]. J Infect Dis, 2009, 200(1):39-47.
|
| [19] |
Society for Maternal-Fetal Medicine (SMFM), Dionne-Odom J, Tita AT, et al. Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission[J]. Am J Obstet Gynecol, 2016, 214(1):6-14.
|
| [20] |
Tan J, Surti B, Saab S. Pregnancy and cirrhosis[J]. Liver Transpl, 2008, 14(8):1081-1091.
|
| [21] |
蒋佩茹，慕永平，张占卿，等. 乙型肝炎病毒感染母婴的传播阻断[J]. 中华传染病杂志，2011, 29(1):58-62.
|
| [22] |
蒋佩茹，林影. 重视肝脏疾病对孕产妇安全的影响[J/CD]．中华产科急救电子杂志，2012, 1(1):6-9.
|
| [23] |
蒋佩茹，李笑天. 妊娠合并病毒性肝炎的产科处理[J]. 实用妇科与产科杂志，2010, 26(4):246-249.
|